CNBC (2020)

The ACTIV-3 trial is one of several ongoing trials that are part of an NIH program to accelerate the development of vaccine treatments.



Comments

No comments yet. Be the first to comment!

Related Chunks

Related chunks with this resource

This Article can be found in 1 chunk
Antibody injections, treatment - a leading candidate for COVID19 Coronavirus cure

MORE RESOURCES FROM SOURCE

More in FoundryBase from   CNBC